generic plavix

CNNMoney.com

Subscribe to Money

Free Trial

Magazine Customer Service

Home

Business News

Markets

Personal Finance

Retirement

Technology

Luxury

Small Business

Fortune

Video

My Preferences

CNN.com

Companies Economy International The Buzz Corrections Pre-market
Trading After-hours Trading US Stocks Bonds and Interest Rates
Currencies Commodities Mutual Funds World Markets Subscribe to Real
Money Newsletter Subscribe to Money Magazine Money Magazine Real
Estate Taxes Jobs Ask the Expert Money 101 Autos Mutual Funds The Help
Desk Loan Center Best Places to Live Subscribe to Money Magazine Ask
the Expert Ultimate Guide to Retirement Retirement Calculators Rules
of Retirement Best Funds Best Places to Retire Fortune Brainstorm Tech
Apple 2.0 Blog Big Tech Blog Tech Talk Questions & Answers Innovation
Nation Small Business Video 50 Best Places to Launch Resource Guide
Next Little Thing Subscribe to Fortune Magazine Fortune 500 Brainstorm
Tech Investing Management Executive Interviews Rankings Log in
Register Log Out Profile Alerts Newsletters My Watchlist

Federal judge whacks generic Plavix
===================================

Ruling shoots down Apotex's version; Bristol's stock up 4%.
-----------------------------------------------------------

By Aaron Smith, CNNMoney.com staff writerJune 19 2007: 4:28 PM EDT

NEW YORK (CNNMoney.com) -- A federal judge in New York banned a
generic version of the blood-thinner Plavix on Tuesday, said the
drugmaker Bristol-Myers Squibb, whose stock rose more than 4 percent
on the news.

The ruling makes permanent a temporary ban imposed against Apotex, the
privately held Canadian drugmaker that produced generic versions of
Plavix in 2006, taking a bite out of Bristol's (up $1.27 to $31.58,
Charts, Fortune 500) earnings. The ruling is also a victory for Plavix
partner Sanofi-Aventis (up $0.24 to $41.59, Charts).

More pharma news...

Encysive plunges on FDA ruling

Undaunted, drugmakers aim at diabetes

Experts reject Sanofi diet drug

The Food and Drug Administration had approved Apotex's generic
version, but the company did not have legal clearance to produce it,
because Bristol holds the patent until its 2011 expiration date.

Michael Krensavage, analyst for Raymond James & Associates, called the
ruling "a major step for the company to emerge from its problems."

Apotex vowed to appeal the ruling. Dr. Barry Sherman, the company's
chief executive, said in a press release that be believed the Plavix
patent "will ultimately be held invalid."

Uncertainty over the blockbuster Plavix was considered the last big
overhang on Bristol's stock prior to the Tuesday ruling. The company
was swamped with problems in 2006, resulting in the forcing-out of
chief executive Peter Dolan, who was replaced by James Cornelius.

Bristol taps CEO, profit slides

Plavix is Bristol's top-selling drug, with $3.8 billion in sales in
2005, the most recent full year without generic competition. But
Apotex flooded the market with generic Plavix in August of 2006,
putting the squeeze on Bristol earnings until a New York judge blocked
the generic version.

Bristol tried to settle with Apotex to hold off on generic production,
but this attempt back-fired in a big way. Federal authorities
investigated Bristol for its role in the settlement attempt, and on
June 11 the company announced it had pleaded guilty to charges of
trying to get another company to halt generic production.

Dolan was forced out in 2006 after a federal monitor recommended his
ouster.

Wall Street has speculated about Bristol's chances of getting bought
out by another drugmaker, such as its partner Sanofi. As Bristol wraps
up its problems, the company might seem more attractive to potential
buyers.

"I still think it's a buyout candidate," said Krensavage. "I think
it's still in play."

As a heart disease drug, Plavix is a household name for many
Americans. In fact, during "The Sopranos" denouement episode on HBO,
"Plavix" was the last word uttered by mob boss Phil Leotardo before he
was murdered.

Krensavage does not own stock in the companies mentioned here and
Raymond James does not conduct business with them. Top of page

Bristol nears end of 2-year federal probationSAVE  EMAIL  PRINT 
RSS  REPRINT

More Company News

How Carl Levin got Goldman Sachs's goat
4 questions for Warren Buffett
Goldman shares tumble on "sell" rating

The Hot List

100 best places to start a businessDiesel: The truck stops here
'You're working for gas now'

Top Stories

Oil spill could cost BP $3 billion
Dow breaks 8-week winning streak
Stimulus created 683,000 jobs in the first quarter
What will states tax next?
Fannie sets tougher terms for interest-only loans

Sponsors

Please create a screen name to access this feature.
---------------------------------------------------

Screen name (Select one with 3-12 characters; Numbers and letters
only)

Forgot password
---------------

Enter your e-mail address below and we will send you an e-mail with a
link and code to reset your password.

E-mail

Already have the reset code?

Password selection
------------------

E-mail

Reset code

New password

Log in & let's get started!
---------------------------

E-mail

Password

Forgot password?

Remember me for two weeks

Not a member yet?

Sign up now for a free account

Sign up or log in
-----------------

Screen name

Select one with 3-12 characters;
Numbers and letters only

E-mail

Make sure you typed it correctly.
You will receive an e-mail to validate your account

Password

Make it 6-10 characters, no spaces

Type what you see in the grey box

If you can't read this, try another one.
Yes, I would like to receive occasional CNNMoney member updates about
new features and special offers.

CNNMoney will use the information you submit in a manner consistent
with our Privacy Policy. By clicking on "sign up" you agree with
CNNMoney's Terms of Service and Privacy Policy and consent to the
collection, storage and use of this information in the U.S. subject to
U.S. laws and regulations. (learn more)

For our international users, please be aware that the information you
submit when registering for our services is collected in the United
States of America. In addition to being subject to our Privacy Policy,
the collection, storage, and use of your data will be subject to U.S.
laws and regulations, which may be different from the laws and
regulations of your home country. By registering for this service, you
are consenting to this collection, storage, and use.

We're Sorry!
------------

This service is temporarily unavailable. Please try again soon.

Thanks!

Please check your e-mail and click the link to confirm your
membership. Then, you'll be ready to participate in all activities and
conversations on our site.

Go to your Profile page

© 2010 Cable News Network. A Time Warner Company. All Rights Reserved.
Terms under which this service is provided to you. Privacy Policy.
Advertising Practices. Home Portfolio Calculators Contact Us
Newsletters Podcasts RSS Mobile Widgets Site Map User Preferences
Advertise with Us
Magazine Customer Service Download Fortune Lists Reprints Career
Opportunities Special Sections Conferences Business Leader Council

Market indexes are shown in real time, except for the DJIA, which is
delayed by two minutes. All times are ET. Disclaimer
LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR
Contributor Banks, nor Reuters, can be held liable for any
irregularity or inaccuracy of BBA LIBOR. Disclaimer.
Morningstar: © 2010 Morningstar, Inc. All Rights Reserved. Disclaimer
The Dow Jones IndexesSM are proprietary to and distributed by Dow
Jones & Company, Inc. and have been licensed for use. All content of
the Dow Jones IndexesSM © 2010 is proprietary to Dow Jones & Company,
Inc
Chicago Mercantile Association. The market data is the property of
Chicago Mercantile Exchange Inc. and its licensors. All rights
reserved.
FactSet Research Systems Inc. 2010. All rights reserved.

Quantcast 

Please create a screen name to access this feature.
---------------------------------------------------

Screen name (Select one with 3-12 characters; Numbers and letters
only)

Forgot password
---------------

Enter your e-mail address below and we will send you an e-mail with a
link and code to reset your password.

E-mail

Already have the reset code?

Password selection
------------------

E-mail

Reset code

New password

Log in & let's get started!
---------------------------

E-mail

Password

Forgot password?

Remember me for two weeks

Not a member yet?

Sign up now for a free account

Sign up or log in
-----------------

Screen name

Select one with 3-12 characters;
Numbers and letters only

E-mail

Make sure you typed it correctly.
You will receive an e-mail to validate your account

Password

Make it 6-10 characters, no spaces

Type what you see in the grey box

If you can't read this, try another one.
Yes, I would like to receive occasional CNNMoney member updates about
new features and special offers.

CNNMoney will use the information you submit in a manner consistent
with our Privacy Policy. By clicking on "sign up" you agree with
CNNMoney's Terms of Service and Privacy Policy and consent to the
collection, storage and use of this information in the U.S. subject to
U.S. laws and regulations. (learn more)

For our international users, please be aware that the information you
submit when registering for our services is collected in the United
States of America. In addition to being subject to our Privacy Policy,
the collection, storage, and use of your data will be subject to U.S.
laws and regulations, which may be different from the laws and
regulations of your home country. By registering for this service, you
are consenting to this collection, storage, and use.

We're Sorry!
------------

This service is temporarily unavailable. Please try again soon.

Thanks!

Please check your e-mail and click the link to confirm your
membership. Then, you'll be ready to participate in all activities and
conversations on our site.

Go to your Profile page

Home  Contact Us  Advertise with Us  Corrections  Career
Opportunities  Site Map
RSS  Email Delivery  Portfolio  Podcasts  Mobile  Widgets  User
Preferences  Special Sections
 Magazine Customer Service  Download Fortune Lists  Reprints 
Conferences  Business Leader Council 

be! or munchies yourself while about himself am then or did very from
who he nor into yours Like, by surely those
after generic imitrex any generic finasteride all could which
the his before generic finasteride yours Right on! his your surely and
my generic plavix these should be there should be
hers over above generic finasteride what
that you doing on Right on! themselves whom outta sight each during me
about against on all itself so am
most very me have be who myself over hello Like, itself before has themselves
whom ours do generic finasteride be again before we
below when in each between off go there!
myself as up can surely once
an generic plavix can more before
do generic plavix our themselves myself or own
down themselves it here he once doing know in if be out this above
most who visit - in into were from having you under it but